Innoviva Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| MRK | Merck | Outperform |
2
|
$130.72 | $130.51 | 7.10% | 11 | $321.69B |
| ABT | Abbott Laboratories | Outperform |
9
|
$106.86 | $118.92 | 18.38% | 7 | $186.15B |
| PFE | Pfizer | Outperform |
2
|
$25.26 | $32.87 | 20.74% | 6 | $147.23B |